AUGTAZ 1000MG/125MG INJECTION
By Augtaz
Rx
1 Injection in a Vial
Composition
Ceftriaxone(1000mg) + Tazobactum(125mg)
Manufacturer - Zuventus Healthcare Ltd
Office No. 5119, 5th Floor, 'D' Wing, Oberoi Garden Estates, Chandivili, Andheri (E), Mumbai - 400 072.
Expires on or after
July, 2025
When using AUGTAZ 1000MG/125MG INJECTION, it's important to be cautious if you have severe liver disease. In such cases, the dosage of AUGTAZ 1000MG/125MG INJECTION may need to be adjusted. It's crucial to consult your doctor before starting treatment with AUGTAZ 1000MG/125MG INJECTION if you have severe liver disease. However, if you have mild to moderate liver disease, dose adjustment of AUGTAZ 1000MG/125MG INJECTION is not typically recommended. Always follow your doctor's guidance and advice regarding the use of AUGTAZ 1000MG/125MG INJECTION in relation to your liver health.
Limited data exists on the use of AUGTAZ 1000MG/125MG INJECTION in people with kidney issues. It's recommended to seek advice from your doctor.
When taking AUGTAZ 1000MG/125MG INJECTION, it is safe to consume alcohol as it does not lead to any harmful effects.
AUGTAZ 1000MG/125MG INJECTION may reduce alertness and cause drowsiness or dizziness. It is advised not to drive if experiencing these symptoms.
AUGTAZ 1000MG/125MG INJECTION is generally safe during pregnancy. Animal studies show minimal harm to the baby, but human studies are limited.
AUGTAZ 1000MG/125MG INJECTION should be used cautiously while breastfeeding. It is advised to temporarily stop breastfeeding until the mother's treatment is finished and the medicine is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹256.5
Inclusive of all taxes
Content verified by
Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024